Insider Trading April 16, 2026 08:51 AM

M-tron Industries EVP Biles Reports Zero-Dollar Sales of Shares and Rights

Regulatory filing shows Linda M. Biles sold common stock and subscription rights at $0.0; company posts strong EPS and launches transferable rights offering

By Ajmal Hussain MPTI
M-tron Industries EVP Biles Reports Zero-Dollar Sales of Shares and Rights
MPTI

Linda M. Biles, Executive Vice President - Finance at M-tron Industries, Inc. (NYSE:MPTI), disclosed the sale of 720 shares of common stock and 2,700 subscription rights in a Form 4 filed with the SEC. Both transactions are reported at a sale price of $0.0. The filing leaves Biles with a direct holding of 28,682 shares and notes outstanding stock options exercisable at $40.32 that expire in April 2030. Separately, M-tron reported fourth-quarter 2025 earnings that beat per-share expectations while narrowly missing revenue forecasts, and the company is proceeding with a transferable subscription rights offering approved by its board.

Key Points

  • Linda M. Biles reported the sale of 720 common shares and 2,700 subscription rights, each at a sale price of $0.0, in a Form 4 filed April 14, 2026.
  • M-tron Industries posted Q4 2025 EPS of $0.99 versus an expected $0.64, while revenue of $14.23 million slightly missed the $14.25 million estimate.
  • The company’s board approved a transferable subscription rights offering; shareholders of record on March 27, 2026 will receive prospectuses expected to be mailed by April 1, 2026.

Linda M. Biles, who serves as Executive Vice President - Finance at M-tron Industries, Inc. (NYSE:MPTI), reported insider sales in a Form 4 filing dated April 14, 2026. The filing records the sale of 720 shares of Common Stock at a reported sale price of $0.0. The same filing shows Biles sold 2,700 Subscription Rights - that is, rights to purchase - also at $0.0.

After these transactions, Biles is listed as directly owning 28,682 shares of M-tron Industries, Inc. The filing additionally records that Biles holds 10,000 Stock Options, which are exercisable at $40.32 and carry an expiration date of 2030-04-04.


Market context and third-party assessment

At the time of the disclosure, M-tron Industries shares are trading at $66. The company’s share price is up 36% over the past year. An InvestingPro analysis cited in the filing materials indicates the stock may be overvalued at current levels. InvestingPro also assigns M-tron Industries a "GREAT" financial health score and notes the company holds more cash than debt, and it offers seven additional ProTips for investors in MPTI.


Recent financial results and corporate action

M-tron Industries reported fourth-quarter 2025 earnings showing an earnings per share (EPS) of $0.99, which exceeded analysts' consensus of $0.64. The filing highlights that the EPS result was 54.69% higher than the forecast. The company’s revenue for the quarter came in at $14.23 million, narrowly below the expected $14.25 million.

The company also announced a transferable subscription rights offering for its shareholders. The Board of Directors approved the offering, and related documents have been filed with the Securities and Exchange Commission. Shareholders of record as of March 27, 2026, are slated to receive the prospectus and associated materials, with those documents expected to be mailed by April 1, 2026. The materials are available via the SEC’s website or directly from the company.


What the filings record

  • Sale by Linda M. Biles of 720 common shares dated April 14, 2026, at $0.0.
  • Sale of 2,700 subscription rights by Biles at $0.0.
  • Biles’ direct ownership after the transactions: 28,682 shares.
  • Outstanding options held by Biles: 10,000 options exercisable at $40.32, expiring 2030-04-04.
  • Q4 2025 EPS: $0.99 vs expected $0.64; Q4 2025 revenue: $14.23 million vs expected $14.25 million.
  • Share price at time of report: $66; 12-month change: +36%.
  • Board-approved transferable subscription rights offering; record date March 27, 2026; materials to be mailed by April 1, 2026.

These items summarize the regulatory disclosure and the company’s recent financial reporting and shareholder action as recorded in the SEC filing and accompanying materials.

Risks

  • The Form 4 shows insider sales reported at a $0.0 price, a factual detail that may raise questions among market participants about the nature of those transactions.
  • InvestingPro analysis cited in the materials indicates MPTI may be overvalued at current levels, which bears on investor valuation assessments in the equities market.
  • Q4 revenue narrowly missed analyst expectations, introducing some uncertainty around near-term top-line momentum for the company.

More from Insider Trading

Ciena SVP Executes $1.33M Stock Sale as Company Reports Rising Backlog and Analyst Upgrades Apr 16, 2026 Saba Capital Disposes of ECAT Shares in $922,505 Transaction Apr 16, 2026 Bonk Inc. Director Expands Stake with $87,575 Purchase Apr 16, 2026 Nordson Director Disposes of $67,098 in Shares as Company Posts In-line Q1 Results Apr 16, 2026 Aqua Capital Adds 1,643 Energizer Shares; Ownership Structure and Analyst Reaction Highlight Caution Apr 16, 2026